These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23202136)

  • 1. Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.
    Canitano R
    Behav Brain Res; 2013 Aug; 251():125-32. PubMed ID: 23202136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders.
    Spooren W; Lindemann L; Ghosh A; Santarelli L
    Trends Pharmacol Sci; 2012 Dec; 33(12):669-84. PubMed ID: 23084458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New experimental treatments for core social domain in autism spectrum disorders.
    Canitano R
    Front Pediatr; 2014; 2():61. PubMed ID: 24999471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders.
    Lukas M; Neumann ID
    Behav Brain Res; 2013 Aug; 251():85-94. PubMed ID: 22981649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.
    Anagnostou E; Soorya L; Brian J; Dupuis A; Mankad D; Smile S; Jacob S
    Brain Res; 2014 Sep; 1580():188-98. PubMed ID: 24508578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blueprint for research on Shankopathies: a view from research on autism spectrum disorder.
    Carbonetto S
    Dev Neurobiol; 2014 Feb; 74(2):85-112. PubMed ID: 24218108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
    Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
    JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders.
    Toro R; Konyukh M; Delorme R; Leblond C; Chaste P; Fauchereau F; Coleman M; Leboyer M; Gillberg C; Bourgeron T
    Trends Genet; 2010 Aug; 26(8):363-72. PubMed ID: 20609491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.
    Grabrucker S; Jannetti L; Eckert M; Gaub S; Chhabra R; Pfaender S; Mangus K; Reddy PP; Rankovic V; Schmeisser MJ; Kreutz MR; Ehret G; Boeckers TM; Grabrucker AM
    Brain; 2014 Jan; 137(Pt 1):137-52. PubMed ID: 24277719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making progress in autism drug discovery.
    Chadman KK
    Expert Opin Drug Discov; 2014 Dec; 9(12):1389-91. PubMed ID: 25251213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders.
    Yamasue H
    Psychiatry Clin Neurosci; 2016 Feb; 70(2):89-99. PubMed ID: 26394796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of synaptogenesis in autism. Pathogenic and therapeutic implications].
    García-Peñas JJ; Domínguez-Carral J; Pereira-Bezanilla E
    Rev Neurol; 2012 Feb; 54 Suppl 1():S41-50. PubMed ID: 22374772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autism spectrum disorders--recent advances in the research on the impairment in social communication].
    Kato N; Yamasue H; Watanabe K; Jinde S; Sadamatsu M
    Brain Nerve; 2010 Sep; 62(9):975-86. PubMed ID: 20844308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural targets in the study and treatment of social cognition in autism spectrum disorder.
    Vahabzadeh A; Landino SM; Finger BC; Carlezon WA; McDougle CJ
    Handb Exp Pharmacol; 2015; 228():309-34. PubMed ID: 25977088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing zebrafish models of autism spectrum disorder (ASD).
    Stewart AM; Nguyen M; Wong K; Poudel MK; Kalueff AV
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():27-36. PubMed ID: 24315837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways to drug development for autism spectrum disorders.
    Hampson DR; Gholizadeh S; Pacey LK
    Clin Pharmacol Ther; 2012 Feb; 91(2):189-200. PubMed ID: 22205199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are retinoids potential therapeutic agents in disorders of social cognition including autism?
    Ebstein RP; Mankuta D; Yirmiya N; Malavasi F
    FEBS Lett; 2011 Jun; 585(11):1529-36. PubMed ID: 21557943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autism spectrum disorder and genes for synaptic proteins].
    Shishido E
    Brain Nerve; 2012 Jan; 64(1):65-70. PubMed ID: 22223503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
    Betancur C
    Brain Res; 2011 Mar; 1380():42-77. PubMed ID: 21129364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments.
    Huffman LC; Sutcliffe TL; Tanner IS; Feldman HM
    J Dev Behav Pediatr; 2011 Jan; 32(1):56-68. PubMed ID: 21160435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.